Skip to Main Content

Author Details

Michael D Prados
University of California san francisco
1987
376
98
PMIDPaper TitleJournal TitlePublished Year
37978951Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.J Clin Oncol2024
37978951Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.J Clin Oncol2024
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
37935104Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.J Clin Oncol2023
37627881Current Strategies for Management of Medulloblastoma.Diagnostics (Basel)2023
37091147Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks.Front Oncol2023
37149933Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology.Neoplasia2023
36581779ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.J Neurooncol2023
37318058PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma.Neuro Oncol2023
36630480Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.Sci Transl Med2023
37443252Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles.Nat Nanotechnol2023
37051331Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study.Neurooncol Adv2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37627881Current Strategies for Management of Medulloblastoma.Diagnostics (Basel)2023
37935104Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.J Clin Oncol2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37318058PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma.Neuro Oncol2023
37149933Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology.Neoplasia2023
37051331Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study.Neurooncol Adv2023
37443252Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles.Nat Nanotechnol2023
37091147Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks.Front Oncol2023
36581779ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.J Neurooncol2023
36630480Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.Sci Transl Med2023
35852795Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.Clin Cancer Res2022
35703183Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.J Clin Invest2022
35852795Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.Clin Cancer Res2022
35703183Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.J Clin Invest2022
33272950Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.AJNR Am J Neuroradiol2021
34125374A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.J Neurooncol2021
33957633BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.Oncology2021
33272950Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.AJNR Am J Neuroradiol2021
34125374A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.J Neurooncol2021
33957633BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.Oncology2021
32257279Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.Neurooncol Pract2020
32027343Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.JAMA Oncol2020
32257279Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.Neurooncol Pract2020
32476174Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas.J Clin Pharmacol2020
32817593Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.J Clin Invest2020
32523649Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).Oncotarget2020
32743548Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.Neurooncol Adv2020
33235994Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.Neurooncol Adv2020
32502458Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.Lancet Oncol2020
32027343Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.JAMA Oncol2020
33235994Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.Neurooncol Adv2020
32743548Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.Neurooncol Adv2020
32817593Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.J Clin Invest2020
32476174Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas.J Clin Pharmacol2020
32502458Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.Lancet Oncol2020
32523649Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).Oncotarget2020
  • 1 - 50 of 752

Recommended Authors

Northwestern University, Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 23
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 13
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 41
Kepler University Hospital
Career Start Year 2006
Number of shared co-authors 10
Northwestern University
Career Start Year 2005
Number of shared co-authors 15
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 15
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 42
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 23
University of Toronto
Career Start Year 2003
Number of shared co-authors 78
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 7
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 1
University of California san francisco
Career Start Year 2001
Number of shared co-authors 26
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 10
The University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 11
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 5
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 22
Lenox Hill Hospital
Career Start Year 1997
Number of shared co-authors 3
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 26
University of Minnesota
Career Start Year 1994
Number of shared co-authors 24
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 10
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 15
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 1
Northwestern University
Career Start Year 1990
Number of shared co-authors 30
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 9
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 7
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 66
Medical University of Vienna
Career Start Year 1987
Number of shared co-authors 2
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year 1984
Number of shared co-authors 12
Nationwide Children's Hospital and The Ohio State University
Career Start Year 1980
Number of shared co-authors 46
Duke University Medical Center
Career Start Year 1978
Number of shared co-authors 6

Collaborators

University of California san francisco
Co-authored papers 79
University of Texas M.D. Anderson Cancer Center
Co-authored papers 60
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 58
Co-authored papers 56
Co-authored papers 41
University of California san francisco
Co-authored papers 40
University of California san francisco
Co-authored papers 39
Co-authored papers 38
National Cancer Institute
Co-authored papers 35
University of California San Francisco
Co-authored papers 33
Co-authored papers 28
Co-authored papers 26
University Children's Hospital Zurich
Co-authored papers 23
Co-authored papers 23
University of Virginia School of Medicine
Co-authored papers 23
Meyer Cancer Center
Co-authored papers 21
Co-authored papers 19
Co-authored papers 19
University of California san francisco
Co-authored papers 17
University of Pittsburgh School of Medicine
Co-authored papers 17
The University of Texas MD Anderson Cancer Center
Co-authored papers 17
Brain Tumor Institute, Children's National Hospital
Co-authored papers 17
Ontario Brain Institute
Co-authored papers 15
Co-authored papers 14
Co-authored papers 13
Co-authored papers 12
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10